Discover

SDGR
Schrödinger, Inc.
29.02
2 x 21.49
2 x 36.80
bid
ask
-
1.22
4.03%
2 @ 07:48 PM
29.11 +0.09 (0.31%)
Ytd62.30%
1y47.68%
28.55
day range
30.22
11.07
52 week range
30.24
Open29.32Prev Close30.24Low28.55High30.22Mkt Cap2.17B
Vol5.23MAvg Vol1.35MEPS-0.73P/EN/AForward P/E-21.50
Beta1.69Short Ratio9.57Inst. Own96.82%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg18.19200-d Avg15.301yr Est21.43

SDGR News

Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday
benzinga.com
Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday

U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal.

Schrödinger: Company Creation Is Now The Real Drug Business
seekingalpha.com
Schrödinger: Company Creation Is Now The Real Drug Business

Schrödinger, Inc. has undergone significant changes, including pipeline cuts and a strategic pivot a

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 202

Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcr

Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcr

Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
zacks.com
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?

Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
gurufocus.com
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14,

benzinga.com
Schrödinger Announces Formation Of Tectora, New Biotechnology Company; Tectora Secures $55M Series A

Schrödinger, Inc. (NASDAQ:SDGR) today announced the formation of Tectora, a new biotechnology compan

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
businesswire.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotech

NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger announced the formation of Tectora, a biotech i

Jupiter Topco LLC Acquires Shares of 28,299 Schrodinger, Inc. $SDGR
defenseworld.net
Jupiter Topco LLC Acquires Shares of 28,299 Schrodinger, Inc. $SDGR

Jupiter Topco LLC bought a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) during the second

Schrödinger to Present at Morgan Stanley Global Healthcare Conference
businesswire.com
Schrödinger to Present at Morgan Stanley Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will par

BlackRock Inc. Buys New Shares in Schrodinger, Inc. $SDGR
defenseworld.net
BlackRock Inc. Buys New Shares in Schrodinger, Inc. $SDGR

BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ: SDGR) during the undefined qua

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
zacks.com
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing

Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Score: 73/100
gurufocus.com
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Score: 73/100

On August 14, 2026, Schrodinger Inc (SDGR) shares fell 4.8% to $17.58, continuing a trend of volatil

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
gurufocus.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restri

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026,

Critical Review: Schrodinger (NASDAQ:SDGR) versus Weave Communications (NYSE:WEAV)
defenseworld.net
Critical Review: Schrodinger (NASDAQ:SDGR) versus Weave Communications (NYSE:WEAV)

Weave Communications (NYSE: WEAV - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report)

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
247wallst.com
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally

Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch g

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
seekingalpha.com
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights
marketbeat.com
Schrodinger Q2 Earnings Call Highlights

Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broa

Schrodinger Q2 Earnings Call Highlights
defenseworld.net
Schrodinger Q2 Earnings Call Highlights

Schrodinger (NASDAQ: SDGR) said second-quarter annual contract value growth accelerated as demand br

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
zacks.com
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Cons

Schrödinger Reports Second Quarter 2026 Financial Results
businesswire.com
Schrödinger Reports Second Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Today Schrödinger announced financial results for the quart

benzinga.com
Schrödinger Rolls Out Early Access Version Of Bunsen

Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, i

Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
benzinga.com
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI

Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de

benzinga.com
Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $17

Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight an

benzinga.com
Schrodinger Affirms FY2026 Sales Guidance of $273.000M-$293.000M vs $252.752M Est

Schrodinger (NASDAQ:SDGR) affirms FY2026 sales outlook from $273.000 million-$293.000 million to $27

benzinga.com
Schrodinger Q1 Adj. EPS $(0.63), Inline, Sales $58.587M Beat $48.002M Estimate

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.63) per share which met the analyst conse

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

benzinga.com
Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $20

Keybanc analyst Brandon Nispel maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers t

benzinga.com
UBS Maintains Neutral on Schrodinger, Lowers Price Target to $13

UBS analyst Michael Yee maintains Schrodinger (NASDAQ:SDGR) with a Neutral and lowers the price t

benzinga.com
Reported earlier, Schrodinger Sees FY2026 Sales $273.000M-$293.000M vs $301.358M Est

Schrodinger (NASDAQ:SDGR) sees FY2026 sales of $273.000 million-$293.000 million vs $301.358 million

benzinga.com
Schrodinger Q4 Sales $87.200M Beat $83.396M Estimate

Schrodinger (NASDAQ:SDGR) reported quarterly sales of $87.200 million which beat the analyst consens

Earnings Scheduled For February 25, 2026
benzinga.com
Earnings Scheduled For February 25, 2026

Earnings Preview For Schrodinger
benzinga.com
Earnings Preview For Schrodinger

Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1
benzinga.com
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1

benzinga.com
Schrödinger Reports 2025 Progress, Highlights Physics+AI Platform Growth, Strategic Collaborations A

Schrödinger, Inc. (NASDAQ:SDGR) provided an update on its progress across the business in 2025 and a

benzinga.com
TD Cowen Maintains Buy on Schrodinger, Lowers Price Target to $24

TD Cowen analyst Brendan Smith maintains Schrodinger (NASDAQ:SDGR) with a Buy and lowers the pric

benzinga.com
Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $25

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers

benzinga.com
UBS Initiates Coverage On Schrodinger with Neutral Rating, Announces Price Target of $18

UBS analyst Michael Yee initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and

benzinga.com
B of A Securities Upgrades Schrodinger to Buy, Maintains Price Target to $24

B of A Securities analyst Michael Ryskin upgrades Schrodinger (NASDAQ:SDGR) from Neutral to Buy a

benzinga.com
Schrodinger Affirms FY2025 Sales Guidance of $243.440M-$257.460M vs $249.717M Est

Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.440 million-$257.460 million to $24

benzinga.com
Schrodinger Q3 Adj. EPS $(0.57) Beats $(0.71) Estimate, Sales $54.324M Beat $51.557M Estimate

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.57) per share which beat the analyst cons

Earnings Scheduled For November 5, 2025
benzinga.com
Earnings Scheduled For November 5, 2025

benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

benzinga.com
Copernic Catalysts Surpasses Final Technical Milestone For Its Jointly-Developed Ammonia Synthesis C

Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (N

benzinga.com
Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $28

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers

benzinga.com
Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts

benzinga.com
Goldman Sachs Initiates Coverage On Schrodinger with Neutral Rating, Announces Price Target of $19

Goldman Sachs analyst Andrea Newkirk initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutr

benzinga.com
Schrödinger Announces A Separation And Release Of Claims Agreement With Dr. Geoffrey Porges As Execu

-SEC Filing-SEC Filing

benzinga.com
What 4 Analyst Ratings Have To Say About Schrodinger